Cargando…
Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
In the era of precision medicine, radiotherapy strategies should be determined based on genetic profiles that predict tumor radiosensitivity. Accordingly, pre-clinical research aimed at discovering clinically applicable genetic profiles is needed. However, how a given genetic profile affects cancer...
Autores principales: | Anakura, Mai, Nachankar, Ankita, Kobayashi, Daijiro, Amornwichet, Napapat, Hirota, Yuka, Shibata, Atsushi, Oike, Takahiro, Nakano, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696360/ https://www.ncbi.nlm.nih.gov/pubmed/31349558 http://dx.doi.org/10.3390/ijms20153635 |
Ejemplares similares
-
The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells
por: Amornwichet, Napapat, et al.
Publicado: (2015) -
Reporting of methodologies used for clonogenic assays to determine radiosensitivity
por: Oike, Takahiro, et al.
Publicado: (2020) -
Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity
por: Matsui, Toshiaki, et al.
Publicado: (2019) -
Chromatin-regulating proteins as targets for cancer therapy
por: Oike, Takahiro, et al.
Publicado: (2014) -
Carbon-Ion Beam Irradiation Kills X-Ray-Resistant p53-Null Cancer Cells by Inducing Mitotic Catastrophe
por: Amornwichet, Napapat, et al.
Publicado: (2014)